Literature DB >> 15703196

Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome.

Michael B Mann1, Craig A Hodges, Ellen Barnes, Hannes Vogel, Terry J Hassold, Guangbin Luo.   

Abstract

Type II Rothmund-Thomson syndrome (Type II RTS) is a rare autosomal recessive genetic disorder characterized by a congenital skin rash, birth defects of the skeleton, genomic instability and cancer predisposition. It is caused by mutations in the RECQL4 gene and thus represents one of the three cancer-prone genetic diseases that are caused by mutations in a RecQ helicase-encoding gene. Genomic instability has been suspected as a major underlying cause of this disease, and analyses of Type II RTS patient-derived cells demonstrate unusually high frequencies of chromosomal aberrations, suggesting the involvement of chromosomal instability. However, the nature of the instability induced by RECQL4 mutations has not been clearly defined. We created a viable Recql4 mutant mouse model. These mice exhibit a distinctive skin abnormality, birth defects of the skeletal system, genomic instability and increased cancer susceptibility in a sensitized genetic background. Thus, they provide a useful model for studying Type II RTS. In addition, we demonstrate that cells from these mutant mice have high frequencies of premature centromere separation and aneuploidy. Thus, our observations provide evidence for a previously unsuspected role for Recql4 in sister-chromatid cohesion, and suggest that the chromosomal instability may be the underlying cause of cancer predisposition and birth defects in these mutant mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703196     DOI: 10.1093/hmg/ddi075

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  74 in total

1.  The RecQ4 orthologue Hrq1 is critical for DNA interstrand cross-link repair and genome stability in fission yeast.

Authors:  Lynda M Groocock; John Prudden; J Jefferson P Perry; Michael N Boddy
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

2.  Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc(min) mice.

Authors:  Yiduo Hu; Xincheng Lu; Guangbin Luo
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 3.  Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability.

Authors:  Sudha Sharma; Kevin M Doherty; Robert M Brosh
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

4.  Dual DNA unwinding activities of the Rothmund-Thomson syndrome protein, RECQ4.

Authors:  Xiaohua Xu; Yilun Liu
Journal:  EMBO J       Date:  2009-01-29       Impact factor: 11.598

Review 5.  The RecQ DNA helicases in DNA repair.

Authors:  Kara A Bernstein; Serge Gangloff; Rodney Rothstein
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

6.  Premature chromatid separation is not a useful diagnostic marker for Cornelia de Lange syndrome.

Authors:  Paola Castronovo; Cristina Gervasini; Anna Cereda; Maura Masciadri; Donatella Milani; Silvia Russo; Angelo Selicorni; Lidia Larizza
Journal:  Chromosome Res       Date:  2009-08-19       Impact factor: 5.239

Review 7.  The role of vertebrate models in understanding craniosynostosis.

Authors:  Greg Holmes
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

Review 8.  RecQ helicases in DNA double strand break repair and telomere maintenance.

Authors:  Dharmendra Kumar Singh; Avik K Ghosh; Deborah L Croteau; Vilhelm A Bohr
Journal:  Mutat Res       Date:  2011-06-13       Impact factor: 2.433

9.  Disruption of Supv3L1 damages the skin and causes sarcopenia, loss of fat, and death.

Authors:  Erin Paul; Rachel Cronan; Paula J Weston; Kim Boekelheide; John M Sedivy; Sang-Yun Lee; David L Wiest; Murray B Resnick; Jan E Klysik
Journal:  Mamm Genome       Date:  2009-01-15       Impact factor: 2.957

10.  Recql5 plays an important role in DNA replication and cell survival after camptothecin treatment.

Authors:  Yiduo Hu; Xincheng Lu; Guangjin Zhou; Ellen L Barnes; Guangbin Luo
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.